United States · Series A startup

Who invested in Antares Therapeutics

One round we have observed, with the 3 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Pharma

Funding summaryUpdated 26 Oct 2026

$177Mraised across 1 round since 2025, from 1 source

Latest round
Series A, $177MMay 2025
Investors
3
See who backed them

The rounds

  1. May 2025
    Series A$177M

    Source recordedSEC filing: $30M sold, first sale May 2025

Everyone who backed them

Cormorant Asset ManagementPrivate equity1round
Omega FundsVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Antares Therapeutics

Who invested in Antares Therapeutics?

Antares Therapeutics's investors include Lightspeed Venture Partners, Cormorant Asset Management and Omega Funds.

How much has Antares Therapeutics raised?

Antares Therapeutics has raised $177M across 1 round since 2025.

When did Antares Therapeutics last raise?

Antares Therapeutics's most recent round was a Series A of $177M in May 2025.

What was Antares Therapeutics's biggest round?

Its most recent round, $177M in May 2025, is also its largest on record.

Who backed Antares Therapeutics first?

Antares Therapeutics's first round on record, in May 2025, was backed by Lightspeed Venture Partners, Cormorant Asset Management and Omega Funds.

What stage is Antares Therapeutics at?

Antares Therapeutics's latest named round is a Series A, in May 2025.

Where is Antares Therapeutics based?

Antares Therapeutics is based in the United States.

Companies like Antares Therapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.